Renfu Pharmaceutical (600079.SH) implemented other risk warnings and suspended trading for 1 day on December 15

Zhitong Financial App News, Renfu Pharmaceutical (600079.SH) issued an announcement. On December 12, 2025, the company received the “Advance Notice of Administrative Penalty” (E Penalty Letter (2025) No. 8) issued by the Hubei Regulatory Bureau of the China Securities Regulatory Commission. According to the contents set out in the “Advance Notice of Administrative Penalty” and according to the relevant provisions of the “Shanghai Stock Exchange Stock Listing Rules (April 2025 Revision)”, the company's shares will be subject to other risk warnings. After implementation, A-shares are abbreviated as ST Renfu.

Trading of the company's stock will be suspended for 1 day on December 15, 2025, and other risk warnings will be implemented from December 16, 2025. After implementing other risk warnings, the company's shares will be traded on the risk warning board, and the daily rise and fall rate of the stock price will be limited to 5%.